Amitiza Treatment

Amitiza or lubiprostone is a relatively new treatment for severe constipation predominant Irritable Bowel Syndrome in women.

The trials of the drug didn't include men so the treatment licence is currently only for women.

It is used for both chronic idiopathic constipation as well as IBS-C.

Amitiza Treatment Facts

Select A Topic:

  • What Is It? - learn more about this drug , how it works and what it's used for here
  • Dosage - how much and how frequently should you take this medication? Learn more
  • Side Effects - what ill effects can you get from taking this medicine? Find out more before you start it
  • Doctors View - My view of taking Amitiza and its use in treating constipation symptoms
  • References - more details of studies that you can look at for yourself should you wish to find more information

What Is Amitiza?

Also known as Lubiprostone, this prostone drug is a ClC-2 chloride channel activator.

CIC-2 channels are chloride channels found in the membranes of human enterocytes or 'cells that line the gut'.

The channels increase the secretion of fluids and electrolytes softening the stool in constipation and allowing the passage of stool through your gut.

Symptoms of constipation including abdominal pain and bloating can settle with this treatment.

Return To Select A Topic

Lubiprostone Dose

Lubiprostone comes as 8 mcg and 24 mcg capsules and should be taken with food and water.

A starting dose of 8 mcg twice a day in IBS-C, the drug dose can be increased to 24 mcg a day can be taken if necessary.

The capsules are lactose free and can be taken in people with lactose intolerance.

Return To Select A Topic

Lubiprostone Side Effects

The drug is generally well tolerated although side effects may include diarrhea, abdominal distension, nausea and vomiting have been reported for this drug.

The symptom of 'dyspnoea' or feeling of breathlessness can occur although this may settle with repeated doses.

Return To Select A Topic

Lubiprostone Contraindications

Lubiprostone is shouldn't be taken in bowel obstruction and in those known to be allergic to the drug.

It should be used with caution in pregnancy and the dose lowered in anyone suffering from liver disease.

Return To Select A Topic

My View On Lubiprostone Treatment

This drug is an exciting new addition in the treatment of constipation-predominant Irritable Bowel Syndrome. 

Because it is still relatively new, it has to be taken with caution and is currently not available in the UK. 

The prostone group has potential though and I expect that the drug, or an evolution of it, will become available in due course.

Return To Select A Topic

Lubiprostone References:

1)   Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Chey WD et al. Aliment Pharmacol Ther. 2012 Mar;35(5):587-99.

2)   Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Fukudo Set al. Neurogastroenterol Motil. 2011 Jun;23(6):544-e205.

3)   Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Drossman DA et al. Aliment Pharmacol Ther. 2009 Feb 1;29(3):329-41.

Leave A Treatment Review!

Have you taken Amitiza your IBS? Why not give a treatment review and pay it forwards to help others.

Leave A Review

Please note that all fields followed by an asterisk must be filled in.

Please enter the word that you see below.

  

Like The Page?

Leave A Comment

Return To Top of Page

› Amitiza